SAO PAULO, Oct 21- Shareholders of Chiquita Brands International Inc. should consider alternatives to a proposed merger with Irish produce firm Fyffes Plc, proxy advisory firm Glass Lewis said on Tuesday. Shareholders are set to vote on Fyffes' revamped all-stock offer of $11.80 per Chiquita share at a special meeting on Oct. 24. "We expect shareholders may...» Read More
April 28- Comcast Corp said it would sell businesses resulting in a loss of 3.9 million video customers as part of its proposed $45.2 billion merger with Time Warner Cable Inc..
ZURICH, April 28- Holcim said there was strong interest in the market for assets it must sell to get the go-ahead for its merger with France's Lafarge, as foreign currency swings weighed on its first-quarter results.
ZURICH, April 28- Swiss cement maker Holcim Ltd posted a 9 percent rise in first-quarter operating profit on Monday, bearing the fruits of a cost-cutting programme as it prepares to merge with French rival Lafarge SA.
Goodman Fielder said it has received a A$1.3 billion ($1.2 billion) bid from Wilmar International but that the offer undervalues the company.
District Judge Colleen Kollar-Kotelly said the settlement, which required American to sell takeoff and landing rights at airports in the New York and Washington areas and airport gates in five other cities, was "within the reaches of the public interest." In Washington, the Justice Department's Antitrust Division welcomed the decision.
In August, the U.S. Justice Department sued to block the merger of AMR Corp and US Airways, saying it would hurt consumers by leading to higher airfares. Several states including Arizona and Texas joined the lawsuit, filed in U.S. District Court for the District of Columbia.
General Electric is in talks with Alstom to take over its global power business. A deal could be announced in days, two sources said.
Medical device maker Zimmer Holdings said it would buy orthopedic products company Biomet to broaden its portfolio of products that treat bone and joint-related disorders.
Drugmakers eager to satisfy shareholders are wheeling, dealing, and in one case even making trades like a pro sports team looking to shake up its roster.
Comcast may divest about 4 million subscribers after its merger with Time Warner Cable and may sell a portion to Charter Communications.
CNBC's Patti Domm discusses the amount of merger activity happening this week with a big three-way deal in the drug industry, and the $46 billion bid by Valeant and activist Bill Ackman for Allergan.
Walgreen's pending acquisition of Alliance Boots can mean lower taxes and a better company, according to activist investor Barry Rosenstein.
"Shark Tank" investor Kevin O'Leary discusses recent mergers between pharmaceutical companies.
Valeant Pharmaceuticals and Bill Ackman are proposing a cash-and-stock deal for Allergan that could be worth about $45 billion.
Netflix announced it intends to raise its membership price for new subscribers, and Netflix CEO Reed Hastings remarked on the proposed Comcast and Time Warner Cable deal during the webcast, with the "Squawk Box" crew.
Pharmaceutical industry observers have been waiting for a rush of deals for months - and they might have finally arrived.
CNBC's Catherine Boyle discusses reports that U.S. drugmaker Pfizer held informal talks with pharmaceutical firm AstraZeneca about a takeover bid.
John Sculley, former Apple CEO and Managing Partner at Inflexionpoint, expects Alibaba to push on with its buying spree after listing in the U.S.
Global drinks firm Diageo on Tuesday announced the launch of a tender offer to acquire up to 26 percent more in India's United Spirits.
Former Time Warner CEO Gerald Levin, gives his strong support for the merger between Comcast and Time Warner Cable. Right now we're in an explosion of programming. Let these companies have the opportunity to create new businesses, says Levin.